Perstorp signs license and collaboration agreement with Polymer Factory
Dendritic materials can be tailored to suit the most various needs. Polymer Factory's CEO Mats Wallnér believes that there is a bright future for these nanometer-sized building blocks in biomedical applications, for example as carriers of active substances in medicines. The active substances can be incorporated in the dendrimer structure and thereby improve solubility and reduce toxicity problems. Inside the body the dendrimers can release the active substances where it is needed most, Wallnér says. Another example, where Polymer Factory is conducting extensive research, is for advanced diagnostic methods such as in vitro tests for allergy towards pharmaceuticals.
Most read news
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.